APIC201405原料药厂清洁验证指南(中英文)GUIDANCEONASPECTSOFCLEANINGVALIDATIONINACTIVEPHARMACEUTICALINGREDIENTPLANTS
原料药工厂中清洁验证指南
May2014
TableofContents1.0FOREWORD
前言2.0OBJECTIVE
目的3.0SCOPE
范围4.0ACCEPTANCECRITERIA
可接受标准4.1Introduction介绍
4.2MethodsofCalculatingAcceptanceCriteria可接受标准的计算方法
4.2.1.Acceptancecriteriausinghealth-baseddata
使用基于健康数据的可接受
标准4.2.2Acceptancecriteriabasedon
TherapeuticDailyDose
基于日治疗剂量的可接受标准4.2.3.AcceptancecriteriabasedonLD50
基于半数致死量的可接受标准4.2.4GeneralLimitasacceptancecriteria
作为可接受标准的通用限度4.2.5SwabLimits
擦拭限度4.2.6RinseLimits淋洗限度
4.2.7Rationalefortheuseofdifferentlimitsinpharmaceuticalandchemicalproduction在药品和化学生产中使用不同限度的合理性
5.0LEVELSOFCLEANING
清洁级别5.1Introduction
介绍5.2CleaningLevels
清洁级别5.3CleaningVerification/Validation
清洁验收/验证6.0CONTROLOFCLEANINGPROCESS清洁过程的控制
7.0BRACKETINGANDWORSTCASE
RATING
分类法和最差情况分级法7.1Introduction
介绍7.2BracketingProcedure
分类法程序7.3CleaningProcedures
清洁程序7.4WorstCaseRating最差情况分级
8.0DETERMINATIONOFTHEAMOUNTOFRESIDUE
残留量检测
8.1Introduction介绍
8.2ValidationRequirements验证要求
8.3SamplingMethods取样方法
8.4AnalyticalMethods分析方法
9.0CLEANINGVALIDATIONPROTOCOL清洁验证方案9.1Background背景
9.2Purpose目的
9.3Scope范围
9.4Responsibility职责
9.5SamplingProcedure取样程序
9.6Testingprocedure分析方法
9.7Acceptancecriteria可接受标准9.8Deviations偏差
9.9Revalidation再验证
10.0VALIDATIONQUESTIONS验证问题
11.0REFERENCES参考文献
12.0GLOSSARY词汇
1.0FOREWORD前言
TheoriginalversionofthisguidancedocumenthasnowbeenupdatedbytheAPICCleaningValidationTaskForceonbehalfoftheActivePharmaceuticalIngredientCommittee(APIC)ofCEFIC.
本指南文件的原版本现已由APIC清洁验证工作组代表CEFIC的APIC委员会进行了更新。
TheTaskForcemembersare:-以下是工作组的成员
AnnickBonneure,APIC,Belgium
TomBuggy,DSMSinochemPharmaceuticals,TheNetherlands
PaulClingan,MacFarlanSmith,UK
AnkeGrootaert,JanssenPharmaceutica,Belgium
PeterMungenast,MerckKGaA,Germany.
LuisaPaulo,HovioneFarmaCienciaSA,Portugal
FilipQuintiens,Genzyme,Belgium
ClaudeVandenbossche,AjinomotoOmnichem,Belgium
JosvanderVen,AspenOssB.V.,TheNetherlands
StefanWienken,BASF,Germany.
Withsupportandreviewfrom:-以下为提供支持和进行审核的人员
PietervanderHoeven,APIC,Belgium
AnthonyStorey,Pfizer,U.K.
RainerFendt,BASF,Germany.
Thesubjectofcleaningvalidationinactivepharmaceuticalingredientmanufacturingplantshascontinuedtoreceivealargeamountofattentionfromregulators,companiesandcustomersalike.
TheintegrationofCleaningValidationwithinaneffectiveQualitySystemsupportedbyQualityRiskManagementProcessesshouldgiveassurancethatAPIManufacturingOperationsareperformedinsuchawaythatRiskstopatientsrelatedtocleaningvalidationareunderstood,assessedforimpactandaremitigatedasnecessary.